immunotherapy

Hair loss affects millions, and a new wave of therapies — from drugs to cell-based treatments — could finally offer safe, effective, and lasting solutions.

As drug discovery grows more complex, the pace of discovery increasingly depends on the tools and people working behind the scenes.

With so many cancer patients not responding to these immunotherapies, researchers are looking for new ways to boost their efficacy.

By starting with T cells from healthy donors, Allogene is manufacturing off-the-shelf CAR T cell therapies that patients don’t have to wait for.

Metabolic conditioning is emerging as a powerful strategy to enhance the potency, persistence, and manufacturability of next-generation cell therapies, providing new hope for hard to treat cancers.

Another death linked to Sarepta’s gene therapy, a promising glioblastoma trial, a rejection for Replimune, and more led the news this week.

A novel immunotherapy targets the liver to promote tolerance to allergens in mice, promising durable allergy relief without the risk of severe reactions.

IO Biotech’s two-pronged cancer vaccine targets tumors and the suppressive immune cells around them, demonstrating promising results in metastatic melanoma.

Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.

Omalizumab could be a better treatment for children with food allergies compared to oral immunotherapy, mainly due to fewer side effects.